Concepedia

Thomas H. Pillow

TH

47

Publications

4K

Citations

31

H-Index

1999

Active since

Affiliations

WuXi AppTec (China)(Current)

Genesys (United States)

Stanford University

Gene Therapy Laboratory

Spirogen (United Kingdom)

Thomas H. Pillow is an author at WuXi AppTec (China) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1999–2024

47

Publications

47

Novel antibody–antibiotic conjugate eliminates intracellular S. aureus

Sophie M. Lehar, Thomas H. Pillow, Min Xu et al. · Nature · 2015 · 815 citations

, , +7

LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity

Akshay T. Krishnamurty, Justin A. Shyer, Minh Thai et al. · Nature · 2022 · 348 citations · Full text

Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters

Elena A. Dubikovskaya, Steve H. Thorne, Thomas H. Pillow et al. · Proceedings of the National Academy of Sciences · 2008 · 250 citations · Full text

, , +19

Antibody Conjugation of a Chimeric BET Degrader Enables <i>in vivo</i> Activity

Thomas H. Pillow, Pragya Adhikari, Robert A. Blake et al. · ChemMedChem · 2019 · 178 citations

Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy

Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake et al. · Journal of Medicinal Chemistry · 2021 · 159 citations

Rows per page

1–5 of 47